• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/16/21 2:14:28 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care
    Get the next $CMD alert in real time by email
    SC 13G/A 1 d138328dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    (Rule 13d-102)

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Cantel Medical Corp.

    (Name of Issuer)

    Common Stock, par value $0.10 per share

    (Title of Class of Securities)

    138098108

    (CUSIP Number)

    December 31, 2020

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

     

     

     


    CUSIP No. 138098108    13G    Page 1 of 9

     

      1.    

      NAMES OF REPORTING PERSONS

     

      Green Equity Investors VII, L.P.

      2.    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☐

     

      3.    

      SEC USE ONLY

     

      4.    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5.     

      SOLE VOTING POWER

     

      0

      6.     

      SHARED VOTING POWER

     

      1,709,694 shares of Common Stock

      7.     

      SOLE DISPOSITIVE POWER

     

      0

      8.     

      SHARED DISPOSITIVE POWER

     

      1,709,694 shares of Common Stock

      9.    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,709,694 shares of Common Stock

    10.    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11.    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    4.0% beneficial ownership of the shares of the Common Stock (based on 42,244,649 shares of Common Stock outstanding as of November 30, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission December 10, 2020).

    12.    

      TYPE OF REPORTING PERSON

     

      PN


    CUSIP No. 138098108    13G    Page 2 of 9

     

      1.    

      NAMES OF REPORTING PERSONS

     

      Green Equity Investors Side VII, L.P.

      2.    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☐

     

      3.    

      SEC USE ONLY

     

      4.    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5.     

      SOLE VOTING POWER

     

      0

      6.     

      SHARED VOTING POWER

     

      1,709,694 shares of Common Stock

      7.     

      SOLE DISPOSITIVE POWER

     

      0

      8.     

      SHARED DISPOSITIVE POWER

     

      1,709,694 shares of Common Stock

      9.    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,709,694 shares of Common Stock

    10.    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11.    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    4.0% beneficial ownership of the shares of the Common Stock (based on 42,244,649 shares of Common Stock outstanding as of November 30, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission December 10, 2020).

    12.    

      TYPE OF REPORTING PERSON

     

      PN


    CUSIP No. 138098108    13G    Page 3 of 9

     

      1.    

      NAMES OF REPORTING PERSONS

     

      GEI Capital VII, LLC

      2.    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☐

     

      3.    

      SEC USE ONLY

     

      4.    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5.     

      SOLE VOTING POWER

     

      0

      6.     

      SHARED VOTING POWER

     

      1,709,694 shares of Common Stock

      7.     

      SOLE DISPOSITIVE POWER

     

      0

      8.     

      SHARED DISPOSITIVE POWER

     

      1,709,694 shares of Common Stock

      9.    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,709,694 shares of Common Stock

    10.    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11.    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    4.0% beneficial ownership of the shares of the Common Stock (based on 42,244,649 shares of Common Stock outstanding as of November 30, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission December 10, 2020).

    12.    

      TYPE OF REPORTING PERSON

     

      OO (Limited Liability Company)


    CUSIP No. 138098108    13G    Page 4 of 9

     

      1.    

      NAMES OF REPORTING PERSONS

     

      LGP Management, Inc.

      2.    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☐

     

      3.    

      SEC USE ONLY

     

      4.    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5.     

      SOLE VOTING POWER

     

      0

      6.     

      SHARED VOTING POWER

     

      1,709,694 shares of Common Stock

      7.     

      SOLE DISPOSITIVE POWER

     

      0

      8.     

      SHARED DISPOSITIVE POWER

     

      1,709,694 shares of Common Stock

      9.    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,709,694 shares of Common Stock

    10.    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11.    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    4.0% beneficial ownership of the shares of the Common Stock (based on 42,244,649 shares of Common Stock outstanding as of November 30, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission December 10, 2020).

    12.    

      TYPE OF REPORTING PERSON

     

      CO


    CUSIP No. 138098108    13G    Page 5 of 9

     

      1.    

      NAMES OF REPORTING PERSONS

     

      Leonard Green & Partners, L.P.

      2.    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☐        (b)  ☐

     

      3.    

      SEC USE ONLY

     

      4.    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

        5.     

      SOLE VOTING POWER

     

      0

      6.     

      SHARED VOTING POWER

     

      1,709,694 shares of Common Stock

      7.     

      SOLE DISPOSITIVE POWER

     

      0

      8.     

      SHARED DISPOSITIVE POWER

     

      1,709,694 shares of Common Stock

      9.    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,709,694 shares of Common Stock

    10.    

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11.    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    4.0% beneficial ownership of the shares of the Common Stock (based on 42,244,649 shares of Common Stock outstanding as of November 30, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission December 10, 2020).

    12.    

      TYPE OF REPORTING PERSON

     

      PN


    CUSIP NO. 138098108    13G    Page 6 of 9

     

    Item 1.

     

      (a)

    Name of Issuer

    Cantel Medical Corp. (“Issuer”)

     

      (b)

    Address of Issuer’s Principal Executive Offices

    150 Clove Road

    Little Falls, New Jersey 07424

    Item 2.

     

      (a)

    Name of Person(s) Filing:

     

      A.

    Green Equity Investors VII, L.P.

     

      B.

    Green Equity Investors Side VII, L.P.

     

      C.

    GEI Capital VII, LLC

     

      D.

    Leonard Green & Partners, L.P.

     

      E.

    LGP Management, Inc.

    Green Equity Investors VII, L.P., a Delaware limited partnership (“GEI VII”) is the direct owner of 783,681 shares of Common Stock of the Issuer (the “GEI VII Shares”). Green Equity Investors Side VII, L.P., a Delaware limited partnership (“GEI Side VII” and together with GEI VII, the “LGP Funds”) is the direct owner of 926,013 shares of Common Stock of the Issuer (the “GEI Side VII Shares” and, collectively with the GEI VII Shares, the “Shares”).

    GEI Capital VII, LLC, a Delaware limited liability company (“Capital”) is the general partner of GEI VII and GEI Side VII. Leonard Green & Partners, L.P., a Delaware limited partnership (“LGP”) is the management company of GEI VII and GEI Side VII. LGP Management, Inc., a Delaware corporation (“LGPM”) is the general partner of LGP.

    Capital, as the general partner of GEI VII and GEI Side VII, LGP, as the manager of GEI VII and GEI Side VII, and LGPM, as the general partner of LGP, directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed to share voting and investment power with respect to the Shares. As such, Capital, LGP, and LGPM may be deemed to be the indirect beneficial owners of the Shares.

    Each of Capital, LGP, and LGPM disclaims beneficial ownership of the Shares reported herein, except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the reporting persons are the beneficial owners of such securities for purposes of Section 13(d), Section 13(g), Section 16, or for any other purposes.

     

      (b)

    Address of Principal Business Office or, if none, Residence

    (A) – (E): 11111 Santa Monica Boulevard, Suite 2000, Los Angeles, CA 90025

     

      (c)

    Citizenship

    (A) – (E): Delaware

     

      (d)

    Title of Class of Securities

    This statement relates to the Issuer’s Common Stock, par value $0.10 per share.

     

      (e)

    CUSIP Number

    138098108


    CUSIP NO. 138098108    13G    Page 7 of 9

     

    Item 3.

    Not applicable.

     

    Item 4.

    Ownership

     

      (a)

    Amount Beneficially Owned:

    See response to Item 9 on each cover page.

     

      (b)

    Percent of class:

    See response to Item 11 on each cover page.

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote:

    See response to Item 5 on each cover page.

     

      (ii)

    Shared power to vote or to direct the vote:

    See response to Item 6 on each cover page.

     

      (iii)

    Sole power to dispose or to direct the disposition of:

    See response to Item 7 on each cover page.

     

      (iv)

    Shared power to dispose or to direct the disposition of:

    See response to Item 8 on each cover page.

     

    Item 5.

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

    Not applicable.

     

    Item 8.

    Identification and Classification of Members of the Group

    Not applicable.

     

    Item 9.

    Notice of Dissolution of Group

    Not applicable.


    CUSIP NO. 138098108    13G    Page 8 of 9

     

    Item 10.

    Certifications

    By signing the below, each of the Reporting Persons certifies that, to the best of its knowledge and belief, the securities referenced to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


    CUSIP NO. 138098108    13G    Page 9 of 9

     

    After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated as of February 16, 2021

     

    Green Equity Investors VII, L.P.

    By: GEI Capital VII, LLC, its

    General Partner

    By:  

    /s/ Andrew Goldberg

      Andrew Goldberg
      Vice President, General Counsel and Secretary
    Green Equity Investors Side VII, L.P.

    By: GEI Capital VII, LLC, its

    General Partner

    By:  

    /s/ Andrew Goldberg

      Andrew Goldberg
      Vice President, General Counsel and Secretary
    GEI Capital VII, LLC
    By:  

    /s/ Andrew Goldberg

      Andrew Goldberg
      Vice President, General Counsel and Secretary
    Leonard Green & Partners, L.P.

    By: LGP Management, Inc., its

    General Partner

    By:  

    /s/ Andrew Goldberg

      Andrew Goldberg
      Vice President, General Counsel and Secretary
    LGP Management, Inc.
    By:  

    /s/ Andrew Goldberg

      Andrew Goldberg
      Vice President, General Counsel and Secretary
    Get the next $CMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cantel Medical Corp.

    4 - CANTEL MEDICAL CORP (0000019446) (Issuer)

    6/2/21 5:27:45 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Cantel Medical Corp.

    4 - CANTEL MEDICAL CORP (0000019446) (Issuer)

    6/2/21 5:28:15 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Cantel Medical Corp.

    4 - CANTEL MEDICAL CORP (0000019446) (Issuer)

    6/2/21 5:27:18 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sanitizing Agents Market Poised for over 7.8% Growth by 2029, Growing by Increasing Investment in The Development of Eco-Friendly Acid-Based Chemicals: States by Exactitude Consultancy

    The Sanitizing Agents Market size is expected to reach 32.34 USD billion by 2029; Sanitizing Agents are a necessary sanitary product for maintaining hygiene and cleanliness in homes and environments PUNE, India, Sept. 21, 2022 /PRNewswire/ -- Sanitation has become an important aspect of the major industrial processes and commercial sectors. Sanitizing agents are being used more frequently to maintain a level of sanitation. The growing awareness of the importance of food product quality is a major reason why demand for sanitizing agents is expected to rise due to their efficiency and cost-effectiveness. Access PDF Sample Report (Including Graphs, Charts & Figures) @ https://exactitudeconsulta

    9/21/22 11:30:00 AM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600

    NEW YORK, May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO) will replace Crocs in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, June 2, 2021. STERIS plc (NYSE:STE) is acquiring Cantel Medical in a deal expected to be completed soon pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector June 2, 2021 S&P MidCap 400 Addition Crocs CROX Consumer Discretionary S&P M

    5/26/21 5:50:00 PM ET
    $STE
    $CMD
    $SPGI
    Industrial Specialties
    Health Care
    Medical/Dental Instruments
    Finance: Consumer Services

    Mar Cor Launches Its Newest and Most Advanced Portable Reverse Osmosis Water System

    The EON™ Portable Dialysis Water System produces high-quality medical water for acute and home hemodialysis use Mar Cor Purification, Inc., a Cantel Medical Corp. (NYSE:CMD) business, announces the launch of the EON™ Portable Dialysis Water System. The portable water purification device uses reverse osmosis (RO) to remove organic and inorganic substances and microbial contaminants from water that feeds into hemodialysis machines to treat hemodialysis patients or related therapies. The water system quickly delivers and efficiently produces medical-grade water for single-patient hemodialysis treatments in hospitals, clinics, skilled nursing centers, and home environments. This press release

    5/6/21 11:04:00 AM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    SEC Filings

    View All

    SEC Form SC TO-I/A filed by Cantel Medical Corp. (Amendment)

    SC TO-I/A - CANTEL MEDICAL LLC (0000019446) (Subject)

    7/2/21 4:06:30 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC TO-I/A filed by Cantel Medical Corp. (Amendment)

    SC TO-I/A - CANTEL MEDICAL LLC (0000019446) (Subject)

    6/29/21 4:16:59 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form 15-12B filed by Cantel Medical Corp.

    15-12B - CANTEL MEDICAL LLC (0000019446) (Filer)

    6/14/21 4:06:30 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    Leadership Updates

    Live Leadership Updates

    View All

    Cantel Announces Senior Leadership Promotions in Dental

    LITTLE FALLS, N.J., Dec. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today the appointment of Andy Xilas to President, Cantel Dental effective January 1, 2021. He will be taking over for Ken Serota, who will be stepping down as President effective December 31, 2020. In addition, Jennifer Naylor has been appointed to the newly created role of Senior Vice President, Infection Prevention and Control Strategy and Education for Cantel. Mr. Xilas and Ms. Naylor both joined Cantel in 2019, as part of Cantel's acquisition of Hu-Friedy and will sit on the Company's Executive Leadership Team. Mr. Xilas has held various positions at Hu-Friedy with increasing responsibility over

    12/3/20 9:00:00 AM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    $CMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Cantel Medical Corp.

    SC 13G - CANTEL MEDICAL LLC (0000019446) (Subject)

    6/10/21 4:11:25 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Cantel Medical Corp. (Amendment)

    SC 13G/A - CANTEL MEDICAL CORP (0000019446) (Subject)

    5/10/21 12:31:25 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - CANTEL MEDICAL CORP (0000019446) (Subject)

    3/10/21 4:38:59 PM ET
    $CMD
    Medical/Dental Instruments
    Health Care